SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011892
Filing Date
2023-07-14
Accepted
2023-07-14 16:25:28
Documents
16
Period of Report
2023-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230714x8k.htm   iXBRL 8-K 45505
2 EX-1.1 tmb-20230714xex1d1.htm EX-1.1 279380
3 EX-5.1 tmb-20230714xex5d1.htm EX-5.1 24287
4 GRAPHIC tmb-20230714xex5d1001.jpg GRAPHIC 4128
5 GRAPHIC tmb-20230714xex5d1004.jpg GRAPHIC 5437
  Complete submission text file 0001558370-23-011892.txt   550381

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230714.xsd EX-101.SCH 3112
7 EX-101.LAB tmb-20230714_lab.xml EX-101.LAB 15918
8 EX-101.PRE tmb-20230714_pre.xml EX-101.PRE 10044
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230714x8k_htm.xml XML 4848
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 231089394
SIC: 2834 Pharmaceutical Preparations